Shanghai Kehua Bio-Engineering Co., Ltd. logo

Shanghai Kehua Bio-Engineering Co., Ltd. (002022)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
5. 50
+0.08
+1.476%
¥
3.45B Market Cap
- P/E Ratio
2.4% Div Yield
11.16M Volume
- Eps
¥ 5.42
Previous Close
Add Transaction
Day Range
5.39 5.56
Year Range
4.47 8
Want to track 002022 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002022 closed today higher at ¥5.5, an increase of 1.476% from yesterday's close, completing a monthly increase of 20.3501% or ¥0.93. Over the past 12 months, 002022 stock lost -7.8727%.
002022 is not paying dividends to its shareholders.
The last earnings report, released on Apr 17, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.1194%, based on the last three reports.
Shanghai Kehua Bio-Engineering Co., Ltd. has completed 7 stock splits, with the recent split occurring on May 27, 2010.
The company's stock is traded on one exchange.

002022 Chart

People also search for

Guangzhou Wondfo Biotech Co., Ltd.
¥ 17.74
-0.8385%
China Reform Health Management Co., Ltd.
¥ 7.42
-1.5915%
Acro Biosystems Co., Ltd.
¥ 82.3
+5.9202%
EIT Environmental Development Group Co., Ltd.
¥ 16.48
-1.3764%
Huapont Life Sciences Co., Ltd.
¥ 4.5
+0.6711%

Shanghai Kehua Bio-Engineering Co., Ltd. (002022) FAQ

What is the stock price today?

The current price is ¥5.50.

On which exchange is it traded?

Shanghai Kehua Bio-Engineering Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002022.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.4%.

What is its market cap?

As of today, the market cap is 3.45B.

Has Shanghai Kehua Bio-Engineering Co., Ltd. ever had a stock split?

Shanghai Kehua Bio-Engineering Co., Ltd. had 7 splits and the recent split was on May 27, 2010.

Shanghai Kehua Bio-Engineering Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Ming Li CEO
XSHE Exchange
CNE000001KC9 ISIN
CN Country
2,033 Employees
10 May 2023 Last Dividend
27 May 2010 Last Split
5 Jul 2004 IPO Date

Overview

Shanghai Kehua Bio-Engineering Co.,Ltd, established in 1981 and based in Shanghai, the People's Republic of China, operates within the biotechnological industry focusing on the research, development, production, and sales of in vitro diagnostic reagents and medical testing equipment both domestically and internationally. The company's extensive product portfolio caters to a variety of medical and research needs, supporting hospitals, disease control and prevention centers, blood centers, bio-pharmaceutical enterprises, and scientific research institutions. Additionally, Shanghai Kehua Bio-Engineering Co.,Ltd has an international presence, exporting its products to global markets.

Products and Services

  • Immunoassay & Clinical Chemistry Systems: These are used for performing various biochemical analyses, essential in diagnosing conditions and monitoring patient health.
  • HIV Colloid Gold Test Kits: A rapid testing tool for the detection of HIV infection, based on the gold colloid method, enabling quick diagnosis and intervention.
  • ELISA HBV Test Kits: These kits employ the Enzyme-Linked Immunosorbent Assay (ELISA) technique for the detection of Hepatitis B virus, facilitating early diagnosis and management of the infection.
  • Renal Disease Management: Providing solutions aimed at diagnosing, monitoring, and managing renal diseases, aiding in early detection and preventing disease progression.
  • Automated Comprehensive Solutions for Nucleic Acid Blood Screening: Advanced systems for screening blood samples for nucleic acids, enhancing the safety and quality of blood transfusions.
  • Automatic Modular and Clinical Chemistry Analyzer: Equipments designed for automating the process of clinical chemistry analysis, increasing efficiency and accuracy in laboratories.
  • Automatic Chemiluminescence Immunoassay Analyzers: These analyzers use chemiluminescence methodology for conducting immunoassays, offering sensitive, fast, and high-throughput options for diagnostic testing.
  • CLIA Reagents Tests: Reagents specifically designed for use in chemiluminescence immunoassays, supporting the detection of various biomarkers.
  • Automatic Microplate Reader and Microplate Washer: Instruments that automate the reading and washing of microplates used in ELISA testing, streamline laboratory workflows.
  • Enzyme-linked Immunoassay Reagents: A broad range of reagents for use in ELISA tests, enabling the detection and quantification of antigens or antibodies in samples.
  • Diagnostic Kit for HIV and SARS-CoV-2 IgM/IgG Antibody: A diagnostic solution for rapidly identifying the presence of antibodies against HIV and SARS-CoV-2, aiding in the management of these infections.
  • Fully Automated Nucleic Acid Blood Screening Laboratory and Molecular Diagnostics Solutions: Comprehensive solutions that automate the process of nucleic acid testing and molecular diagnostics, facilitating accurate and efficient disease diagnosis and management.

Contact Information

Address: Caohejing Hi-Tech Park, Shanghai, China, 200233
Phone: 86 21 6495 0625